Your institution may have access to this item. Find your institution then sign in to continue.
Title
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.
Authors
Raz, I; Hanefeld, M; Xu, L; Caria, C; Williams-Herman, D; Khatami, H; Sitagliptin Study 023 Group
Abstract
The aim of this study was to assess the efficacy and safety of sitagliptin (MK-0431) as monotherapy in patients with type 2 diabetes mellitus and inadequate glycaemic control (HbA(1c) > or =7% and < or =10%) on exercise and diet.